ORDER A TEST Log In Contact Us

Resources

Webinars

Filter By
  • image description
    06/29/2021

    Identification of patients for germline testing

    The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 4

    Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

    Watch replay
  • image description
    06/29/2021

    Experience with interpreting somatic reports

    The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 3

    Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

    Watch replay
  • image description
    06/29/2021

    Tumor-normal matched sequencing and platforms utilized for tumor profiling

    The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 2

    Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

    Watch replay
  • image description
    06/29/2021

    Defining germline sequencing and incidental germline findings

    The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 1

    Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

    Watch replay
  • image description
    06/01/2021

    Transforming immunotherapy with Tempus

    See how A2 Biotherapeutics is enhancing its clinical development progress for a cell therapy using HLA LOH as a biomarker and Tempus' comprehensive immunotherapy platform.

    Speakers: Dr. Denise Lau, Senior Director of Computational Immunology, Tempus; Dr. William Go, M.D., SVP and Head of Development

    Watch replay
1 2